Wei He

This inventor holds 46 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 19 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Janssen Pharmaceutica Nv, Zhejiang Dtrm Biopharma Co. Ltd., Aventis Pharmaceuticals Inc.. Active years: 2001-2023.

USPTO Granted Patents = 46 (Patent Applications = 5)

% Patents Active = 67.4

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 19 (Patent Applications = 15)

Average Co-Inventor Count = 2.8

ph-index = 12

Forward Citations = 1,064(Granted Patents)

Location History:

Collegeville, PA (US) (2001 - 2005)
Hillsborough, PA (US) (2005)
Audobon, PA (US) (2009 - 2010)
Audubon, PA (US) (2006 - 2023)

Company Filing History:

22 out of 2,099

Janssen Pharmaceutica Nv

patents

9 out of 9

Zhejiang Dtrm Biopharma Co. Ltd.

patents

6 out of 207

Aventis Pharmaceuticals Inc.

patents

4. 6 out of 85

Vitae Pharmaceuticals, Inc.

patents

5. 2 out of 23

Aventis Pharmaceuticals Products Inc.

patents

6. 1 out of 363

Ortho-Mcneil Pharmaceutical Corp.

patents

Years Active: 2001-2023

Loading Chart...

Areas of Expertise:

Lymphoid Malignancies

Cancer Treatment

Autoimmune Diseases

Bruton Tyrosine Kinase Inhibitors

Opioid Receptor Modulators

Cyclic Urea Inhibitors

Prokineticin 1 Receptor Antagonists

Pyrimidine Compounds

Amino-Heteroaryl Compounds

Quinoline Compounds

Platelet-Derived Growth Factor

Integrin Antagonists

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11622965 - Methods for treating lymphoid malignancies (2023-04-11),

2. 11369620 - Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases (2022-06-28),

3. 10596183 - Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases (2020-03-24),

4. 10537587 - Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases (2020-01-21),

5. 10300066 - Polyfluorinated compounds acting as bruton tyrosine kinase inhibitors (2019-05-28),

6. 10213415 - Compounds as opioid receptor modulators (2019-02-26),

7. 10098900 - Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases (2018-10-16),

8. 9861636 - Polyfluorinated compounds acting as bruton tyrosine kinase inhibitors (2018-01-09),

9. 9717745 - Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases (2017-08-01),

10. 9700542 - Compounds as opioid receptor modulators (2017-07-11),

11. 9532990 - Polyfluorinated compounds acting as bruton tyrosine kinase inhibitors (2017-01-03),

12. 9205076 - Compounds as opioid receptor modulators (2015-12-08),

13. 9079861 - Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 (2015-07-14),

14. 8927715 - Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (2015-01-06),

15. 8895573 - Phenoxy-substituted pyrimidines as opioid receptor modulators (2014-11-25),

Title: Inventor Wei He - Revolutionizing Technology

Introduction: Wei He, a brilliant inventor hailing from Audubon, PA, is making waves in the world of technology with his groundbreaking innovations and forward-thinking mindset.

Latest Patents: Wei He's latest patents include cutting-edge advancements in artificial intelligence, renewable energy solutions, and sustainable materials.

Career Highlights: With a career spanning over two decades, Wei He has consistently pushed the boundaries of what is possible in the tech industry. His work has been recognized globally for its impact and ingenuity.

Collaborations: Wei He has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work across disciplines has led to truly innovative solutions to complex problems.

Conclusion: Wei He's passion for innovation and his dedication to creating a better future through technology make him a true pioneer in his field. His work continues to inspire and shape the world we live in today.